The medical cannabis market is undergoing rapid changes. Worldwide regulatory changes and numerous new developments in medical cannabis products are leading to a growing need for highly professional services. Diapharm, the leading consultant and service provider for strategic solutions, regulatory and QM tasks, and the laboratory Diapharm Analytics, a Tentamus company, are happy to support you in the realization of your cannabis projects.
As a member of the Tentamus Group, Diapharm Analytics offers an all-round service in cooperation with our partner laboratories. These include:
Cannabis flos
- batch release testing
- Stability studies
- Clinical studies
New Formulations of cannabis flos:
- Method development and method validation
- Analysis and monitoring of product development
- Stability studies
- Clinical studies
In the run-up, Diapharm can provide strategic, regulatory and QM consulting. We can prepare all documents and manage all necessary processes to establish our clients as importers (2001/83/EC Art. 40 et seqq.) and/or wholesale distributors (Art. 76 et seqq.) with a licence pursuant to the German Narcotic Drugs Act (BTMG) for medical cannabis. Contact us!
Tentamus Group GmbH
Tentamus Group GmbH was founded in 2011. Tentamus is a global product and safety group with a core presence in Europe, UK, Israel, China and the USA. Accredited and licensed Tentamus Group tests, audits and consults on all products involving the human body (food & feed, pharmaceuticals & medical, agrochemicals, cosmetics, agriculture & environment and nutraceutical & supplements). Tentamus Group is represented in over 50 locations worldwide. More than 2,500 highly-trained staff members work in over 1 million square feet of laboratory and office spaces. For further information please visit www.tentamus.com.
Tentamus Group
An der Industriebahn 5
13088 Berlin, Germany
www.tentamus.com
Tentamus Group GmbH
An der Industriebahn 26
13088 Berlin
Telefon: +49 (30) 206038-230
Telefax: +49 (30) 206038-190
http://www.tentamus.com
Managing Director Diapharm Analytics
Telefon: +49 441 361 3265 449
E-Mail: Serap.Acikgoez@diapharm.de
